查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1650414

視網膜靜脈阻塞市場；治療類型：- 2024 年至 2034 年全球產業分析、規模、佔有率、成長、趨勢與預測

Retinal Vein Occlusion Market; Treatment Type: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 241 Pages | 商品交期: 2-10個工作天內

價格

視網膜靜脈阻塞市場 - 報告範圍

TMR 關於全球視網膜靜脈阻塞市場的報告研究了過去和當前的成長趨勢和機會，以便在 2024 年至 2034 年預測期內獲得有關市場指標的寶貴見解。 該報告提供了 2018 年至 2034 年期間全球視網膜靜脈阻塞市場的收入，以 2024 年為基準該報告也提供了 2024 年至 2034 年全球視網膜靜脈阻塞市場的年複合成長率(CAGR%)。

該報告是經過廣泛研究後編寫的。初步研究涉及大部分研究工作，其中分析師對關鍵意見領袖、產業領袖和輿論製造者進行訪談。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解視網膜靜脈阻塞市場。

市場概況
2023 年市場價值 28億美元
2034 年的市場價值 55億美元
複合年成長率 6.7%

該報告深入探討了全球視網膜靜脈阻塞市場的競爭格局。我們已經確定了在全球視網膜靜脈阻塞市場中運作的關鍵參與者，並根據各種屬性對每位參與者進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告介紹的全球視網膜靜脈阻塞市場參與者的屬性。

目錄

第 1 章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第4章：市場概況

  • 介紹
  • 概述
  • 市場動態
  • 2020 年至 2034 年全球市場分析與預測

第5章：關鍵見解

  • 監管情景
  • 大環境分析
  • 各地區/國家醫療保健支出（人均醫療保健支出總額，美元，2022 年）
  • 市場進入策略
  • 價值鏈分析
  • 治療演算法
  • 重要產業活動

第6章：全球市場分析與預測：依疾病類型

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2034 年按疾病類型分類的市場價值預測
    • 中央
    • 分支
  • 不同疾病類型的市場吸引力

第7章：全球市場分析及預測：依治療類型

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2034 年按治療類型分類的市場價值預測
    • 藥物治療
      • 抗血管內皮生長因子（抗 VEGF）藥物
      • 皮質類固醇藥物
    • 雷射治療
      • 全視網膜光凝固術
      • 聚焦雷射
    • 玻璃體切除術
  • 各治療類型的市場吸引力

第 8 章：全球市場分析與預測：按最終用戶

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2034 年終端用戶市值預測
    • 醫院及門診手術中心
    • 眼科診所
    • 零售藥局
    • 其他
  • 終端用戶的市場吸引力

第9章：全球市場分析及預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第 10 章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區

第 12 章：亞太市場分析與預測

  • 中國
  • 日本
  • 印度
  • 澳洲和紐西蘭
  • 亞太其他地區

第 13 章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2023 年）
  • 公司簡介
    • Bayer AG
    • Alimera Sciences
    • Abbivie
    • Annexin Pharmaceuticals AB
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • IRIDEX Corporation
    • Lumenis
    • Nidek Co., Ltd.
    • Regeneron Pharmaceuticals, Inc.
Product Code: TMRGL60489

Retinal Vein Occlusion Market - Scope of Report

TMR's report on the global retinal vein occlusion market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global retinal vein occlusion market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global retinal vein occlusion market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the retinal vein occlusion market.

Market Snapshot
Market Value in 2023US$ 2.8 Bn
Market Value in 2034US$ 5.5 Bn
CAGR6.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global retinal vein occlusion market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global retinal vein occlusion market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global retinal vein occlusion market.

The report delves into the competitive landscape of the global retinal vein occlusion market. Key players operating in the global retinal vein occlusion market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global retinal vein occlusion market profiled in this report.

Key Questions Answered in Global retinal vein occlusion Market Report:

  • What is the sales/revenue generated by retinal vein occlusion across all regions during the forecast period?
  • What are the opportunities in the global retinal vein occlusion market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Retinal Vein Occlusion Market - Research Objectives and Research Approach

The comprehensive report on the global retinal vein occlusion market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global retinal vein occlusion market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global retinal vein occlusion market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Retinal Vein Occlusion Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Retinal Vein Occlusion Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Scenario
  • 5.2. PESTLE Analysis
  • 5.3. Healthcare Expenditure by Region/Country (Health spending Total, US dollars/capita, 2022)
  • 5.4. Go-to-Market Strategies for Retinal Vein Occlusion Market
  • 5.5. Value Chain Analysis
  • 5.6. Treatment Algorithm
  • 5.7. Key Industry Events

6. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Disease Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Disease Type, 2020-2034
    • 6.3.1. Central Retinal Vein Occlusion
    • 6.3.2. Branch Retinal Vein Occlusion
  • 6.4. Market Attractiveness By Disease Type

7. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Treatment Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Treatment Type, 2020-2034
    • 7.3.1. Pharmacological Treatment
      • 7.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 7.3.1.2. Corticosteroid Drugs
    • 7.3.2. Laser Treatment
      • 7.3.2.1. Panretinal Photocoagulation
      • 7.3.2.2. Focal Laser
    • 7.3.3. Vitrectomy
  • 7.4. Market Attractiveness By Treatment Type

8. Global Retinal Vein Occlusion Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospitals and Ambulatory Surgical Centers
    • 8.3.2. Ophthalmology Clinics
    • 8.3.3. Retail Pharmacies
    • 8.3.4. Others
  • 8.4. Market Attractiveness By End-user

9. Global Retinal Vein Occlusion Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Retinal Vein Occlusion Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Disease Type, 2020-2034
    • 10.2.1. Central Retinal Vein Occlusion
    • 10.2.2. Branch Retinal Vein Occlusion
  • 10.3. Market Value Forecast By Treatment Type, 2020-2034
    • 10.3.1. Pharmacological Treatment
      • 10.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 10.3.1.2. Corticosteroid Drugs
    • 10.3.2. Laser Treatment
      • 10.3.2.1. Panretinal Photocoagulation
      • 10.3.2.2. Focal Laser
    • 10.3.3. Vitrectomy
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospitals and Ambulatory Surgical Centers
    • 10.4.2. Ophthalmology Clinics
    • 10.4.3. Retail Pharmacies
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Disease Type
    • 10.6.2. By Treatment Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Retinal Vein Occlusion Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Disease Type, 2020-2034
    • 11.2.1. Central Retinal Vein Occlusion
    • 11.2.2. Branch Retinal Vein Occlusion
  • 11.3. Market Value Forecast By Treatment Type, 2020-2034
    • 11.3.1. Pharmacological Treatment
      • 11.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 11.3.1.2. Corticosteroid Drugs
    • 11.3.2. Laser Treatment
      • 11.3.2.1. Panretinal Photocoagulation
      • 11.3.2.2. Focal Laser
    • 11.3.3. Vitrectomy
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospitals and Ambulatory Surgical Centers
    • 11.4.2. Ophthalmology Clinics
    • 11.4.3. Retail Pharmacies
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Disease Type
    • 11.6.2. By Treatment Type
    • 11.6.3. By End-user
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Retinal Vein Occlusion Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Disease Type, 2020-2034
    • 12.2.1. Central Retinal Vein Occlusion
    • 12.2.2. Branch Retinal Vein Occlusion
  • 12.3. Market Value Forecast By Treatment Type, 2020-2034
    • 12.3.1. Pharmacological Treatment
      • 12.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 12.3.1.2. Corticosteroid Drugs
    • 12.3.2. Laser Treatment
      • 12.3.2.1. Panretinal Photocoagulation
      • 12.3.2.2. Focal Laser
    • 12.3.3. Vitrectomy
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospitals and Ambulatory Surgical Centers
    • 12.4.2. Ophthalmology Clinics
    • 12.4.3. Retail Pharmacies
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Disease Type
    • 12.6.2. By Treatment Type
    • 12.6.3. By End-user
    • 12.6.4. By Country / Sub-region

13. Latin America Retinal Vein Occlusion Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Disease Type, 2020-2034
    • 13.2.1. Central Retinal Vein Occlusion
    • 13.2.2. Branch Retinal Vein Occlusion
  • 13.3. Market Value Forecast By Treatment Type, 2020-2034
    • 13.3.1. Pharmacological Treatment
      • 13.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 13.3.1.2. Corticosteroid Drugs
    • 13.3.2. Laser Treatment
      • 13.3.2.1. Panretinal Photocoagulation
      • 13.3.2.2. Focal Laser
    • 13.3.3. Vitrectomy
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospitals and Ambulatory Surgical Centers
    • 13.4.2. Ophthalmology Clinics
    • 13.4.3. Retail Pharmacies
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Disease Type
    • 13.6.2. By Treatment Type
    • 13.6.3. By End-user
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Retinal Vein Occlusion Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Disease Type, 2020-2034
    • 14.2.1. Central Retinal Vein Occlusion
    • 14.2.2. Branch Retinal Vein Occlusion
  • 14.3. Market Value Forecast By Treatment Type, 2020-2034
    • 14.3.1. Pharmacological Treatment
      • 14.3.1.1. Anti-vascular endothelial growth factor (anti-VEGF) Drugs
      • 14.3.1.2. Corticosteroid Drugs
    • 14.3.2. Laser Treatment
      • 14.3.2.1. Panretinal Photocoagulation
      • 14.3.2.2. Focal Laser
    • 14.3.3. Vitrectomy
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospitals and Ambulatory Surgical Centers
    • 14.4.2. Ophthalmology Clinics
    • 14.4.3. Retail Pharmacies
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Disease Type
    • 14.6.2. By Treatment Type
    • 14.6.3. By End-user
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Alimera Sciences
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Abbivie
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Annexin Pharmaceuticals AB
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. F. Hoffmann-La Roche AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Novartis AG
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. IRIDEX Corporation
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Lumenis
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Nidek Co., Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Regeneron Pharmaceuticals, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments

Retinal Vein Occlusion Market

Retinal Vein Occlusion Industry

Retinal Vein Occlusion Market Size

Retinal Vein Occlusion Market Share

Retinal Vein Occlusion Market Growth

Retinal Vein Occlusion Market Analysis

Retinal Vein Occlusion Market Demand

Retinal Vein Occlusion Market Forecast

Retinal Vein Occlusion Market Trends

List of Tables

  • Table 01: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Disease Type, 2020-2034
  • Table 02: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 03: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 04: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 05: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By End-user, 2020-2034
  • Table 06: Global Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Region, 2020-2034
  • Table 07: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 08: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 09: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 10: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 11: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 12: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 15: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 16: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 17: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 18: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 19: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 20: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 21: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 22: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 23: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 24: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 25: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 27: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 28: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 29: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 30: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 31: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 32: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by Disease Type, 2020-2034
  • Table 33: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Treatment Type, 2020-2034
  • Table 34: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Pharmacological Treatment, 2020-2034
  • Table 35: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, By Laser Treatment, 2020-2034
  • Table 36: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Retinal Vein Occlusion Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Retinal Vein Occlusion Market Value Share, by Disease Type, 2023
  • Figure 03: Global Retinal Vein Occlusion Market Value Share, By Treatment Type, 2023
  • Figure 04: Global Retinal Vein Occlusion Market Value Share, by End-user, 2023
  • Figure 05: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Disease Type, 2023 and 2034
  • Figure 06: Global Retinal Vein Occlusion Market Share Analysis, By Disease Type, 2023
  • Figure 07: Global Retinal Vein Occlusion Market Share Analysis, By Disease Type, 2034
  • Figure 08: Global Retinal Vein Occlusion Market Attractiveness Analysis, By Disease Type, 2024-2034
  • Figure 09: Global Retinal Vein Occlusion Market Value (US$ Bn), by Central Retinal Vein Occlusion, 2020-2034
  • Figure 10: Global Retinal Vein Occlusion Market Value Share Analysis, by Central Retinal Vein Occlusion, 2023 and 2034
  • Figure 11: Global Retinal Vein Occlusion Market Value (US$ Bn), by Branch Retinal Vein Occlusion, 2020-2034
  • Figure 12: Global Retinal Vein Occlusion Market Value Share Analysis, by Branch Retinal Vein Occlusion, 2023 and 2034
  • Figure 13: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 14: Global Retinal Vein Occlusion Market Share Analysis, By Treatment Type, 2023
  • Figure 15: Global Retinal Vein Occlusion Market Share Analysis, By Treatment Type, 2034
  • Figure 16: Global Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 17: Global Retinal Vein Occlusion Market Value (US$ Bn), by Pharmacological Treatment, 2020-2034
  • Figure 18: Global Retinal Vein Occlusion Market Value Share Analysis, by Pharmacological Treatment, 2023 and 2034
  • Figure 19: Global Retinal Vein Occlusion Market Value (US$ Bn), by Laser Treatment, 2020-2034
  • Figure 20-: Global Retinal Vein Occlusion Market Value Share Analysis, by Laser Treatment, 2023 and 2034
  • Figure 21: Global Retinal Vein Occlusion Market Value (US$ Bn), by Vitrectomy, 2020-2034
  • Figure 22: Global Retinal Vein Occlusion Market Value Share Analysis, by Vitrectomy, 2023 and 2034
  • Figure 23: Global Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By End-user, 2023 and 2034
  • Figure 24: Global Retinal Vein Occlusion Market Share Analysis, By End-user, 2023
  • Figure 25: Global Retinal Vein Occlusion Market Share Analysis, By End-user, 2034
  • Figure 26: Global Retinal Vein Occlusion Market Attractiveness Analysis, By End-user, 2024-2034
  • Figure 27: Global Retinal Vein Occlusion Market Value (US$ Bn), by Hospitals and Ambulatory Surgical Centers, 2020-2034
  • Figure 28: Global Retinal Vein Occlusion Market Value Share Analysis, by Hospitals and Ambulatory Surgical Centers, 2023 and 2034
  • Figure 29: Global Retinal Vein Occlusion Market Value (US$ Bn), by Ophthalmology Clinics, 2020-2034
  • Figure 30: Global Retinal Vein Occlusion Market Value Share Analysis, by Ophthalmology Clinics, 2023 and 2034
  • Figure 31: Global Retinal Vein Occlusion Market Value (US$ Bn), by Retail Pharmacies, 2020-2034
  • Figure 32: Global Retinal Vein Occlusion Market Value Share Analysis, by Retail Pharmacies, 2023 and 2034
  • Figure 33: Global Retinal Vein Occlusion Market Value (US$ Bn), By Others, 2020-2034
  • Figure 34: Global Retinal Vein Occlusion Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 35: Global Retinal Vein Occlusion Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 36: Global Retinal Vein Occlusion Market Share Analysis, by Region, 2023
  • Figure 37: Global Retinal Vein Occlusion Market Share Analysis, by Region, 2034
  • Figure 38: Global Retinal Vein Occlusion Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 39: North America Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 40: North America Retinal Vein Occlusion Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 41: North America Retinal Vein Occlusion Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 42: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 43: North America Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 44: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 45: North America Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 46: North America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 47: North America Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 48: Europe Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 49: Europe Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 50: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 51: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 52: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 53: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 54: Europe Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 55: Europe Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 56: Europe Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 57: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 58: Asia Pacific Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 59: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 60: Asia Pacific- Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 61: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 62: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 63: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 64: Asia Pacific Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 65: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 67: Latin America Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 69: Asia Pacific- Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 70: Asia Pacific Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 71: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 72: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 73: Latin America Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 74: Latin America Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 75: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 76: Middle East & Africa Retinal Vein Occlusion Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 77: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 78: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by Disease Type, 2023 and 2034
  • Figure 79: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 80: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, By Treatment Type, 2023 and 2034
  • Figure 81: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, By Treatment Type, 2024-2034
  • Figure 82: Middle East & Africa Retinal Vein Occlusion Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 83: Middle East & Africa Retinal Vein Occlusion Market Attractiveness Analysis, by End-user, 2024-2034